Bulletin
Investor Alert

New York Markets Close in:

Market Pulse Archives

Oct. 4, 2021, 7:46 a.m. EDT

OpGen stock rockets after upbeat revenue update

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    OpGen Inc. (OPGN)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Tomi Kilgore

Shares of OpGen Inc. /zigman2/quotes/207999856/composite OPGN -0.03% rocketed 31.9% in active premarket trading Monday, after the precision medicine company provided a revenue update following the recent Food and Drug Administration clearance of its Acuitas AMR Gene Panel to aid in the diagnosis of severe infections. Trading volume spiked to 5.1 million shares ahead of the open, compared with the full-day average of about 1.8 million shares. The company said preliminary third-quarter revenue was approximately $1.2 million, compared with the FactSet consensus of $800,000. The stock has rallied 35.3% year to date through Friday, while the S&P 500 /zigman2/quotes/210599714/realtime SPX +1.49% has gained 16.0%.

/zigman2/quotes/207999856/composite
US : U.S.: Nasdaq
$ 0.39
-0.0001 -0.03%
Volume: 33,967
May 23, 2022 1:01p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$18.02 million
Rev. per Employee
$39,859
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
3,959.67
+58.31 +1.49%
Volume: 1.20B
May 23, 2022 1:05p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.